PLXP PLx Pharma Inc.

6.75
-0.09  -1%
Previous Close 6.84
Open 6.85
Price To book 4.82
Market Cap 58871414
Shares 8,721,691
Volume 752
Short Ratio 0.45
Av. Daily Volume 18,770

SEC filingsSee all SEC filings

  1. SC 13D - General statement of acquisition of beneficial ownership 171214591
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171191736
  3. 8-K - Current report 171159757
  4. 8-K - Current report 171105443
  5. 8-K - Current report 171091881

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data did not meet endpoints - October 25, 2016.
Locilex
Mild infections of diabetic foot ulcers

SEC Filings

  1. SC 13D - General statement of acquisition of beneficial ownership 171214591
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171191736
  3. 8-K - Current report 171159757
  4. 8-K - Current report 171105443
  5. 8-K - Current report 171091881
  6. CT ORDER - Confidential treatment order 171042741
  7. 8-K/A [Amend] - Current report 171031922
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 171023919
  9. 8-K - Current report 171019754
  10. D - Notice of Exempt Offering of Securities 17934946